about
The ubiquitin ligase Stub1 negatively modulates regulatory T cell suppressive activity by promoting degradation of the transcription factor Foxp3The neuropeptide alpha-melanocyte-stimulating hormone is critically involved in the development of cytotoxic CD8+ T cells in mice and humansG protein-coupled receptor 83 overexpression in naive CD4+CD25- T cells leads to the induction of Foxp3+ regulatory T cells in vivo.Who is really in control of skin immunity under physiological circumstances - lymphocytes, dendritic cells or keratinocytes?Dendritic cells and T cells in the regulation of cutaneous immunity.Molecular and cellular mechanisms of photocarcinogenesis.Terminal signal: anti-inflammatory effects of α-melanocyte-stimulating hormone related peptides beyond the pharmacophore.Sensitive skin.The tripeptide KdPT ameliorates ongoing psoriasis-like skin inflammation in murine and human skin.An important role of CD80/CD86-CTLA-4 signaling during photocarcinogenesis in mice.Melanocortin-1 receptor activation is neuroprotective in mouse models of neuroinflammatory disease.Cutaneous RANK-RANKL Signaling Upregulates CD8-Mediated Antiviral Immunity during Herpes simplex Virus Infection by Preventing Virus-Induced Langerhans Cell Apoptosis.In vitro induced CD8+ regulatory T cells inhibit skin inflammation.Antibody production using a ciliate generates unusual antibody glycoforms displaying enhanced cell-killing activity.Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity.The fungal acl1 and acl2 genes encode two polypeptides with homology to the N- and C-terminal parts of the animal ATP citrate lyase polypeptide.α-MSH-stimulated tolerogenic dendritic cells induce functional regulatory T cells and ameliorate ongoing skin inflammation.Heart-directed expression of a human cardiac isoform of cAMP-response element modulator in transgenic mice.IL-12 breaks dinitrothiocyanobenzene (DNTB)-mediated tolerance and converts the tolerogen DNTB into an immunogen.Endothelial basement membrane laminin alpha5 selectively inhibits T lymphocyte extravasation into the brain.FK506 controls CD40L-induced systemic autoimmunity in mice.CD4+ T cell-associated pathophysiology critically depends on CD18 gene dose effects in a murine model of psoriasis.Dual action by fumaric acid esters synergistically reduces adhesion to human endothelium.Novel everolimus-loaded nanocarriers for topical treatment of murine experimental autoimmune uveoretinitis (EAU).Vitamin D receptor signaling contributes to susceptibility to infection with Leishmania major.The single-chain anti-TNF-α antibody DLX105 induces clinical and biomarker responses upon local administration in patients with chronic plaque-type psoriasis.Dihydroavenanthramide D inhibits mast cell degranulation and exhibits anti-inflammatory effects through the activation of neurokinin-1 receptor.Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cellsIchthyosis vulgaris: novelFLGmutations in the German population and high presence of CD1a+ cells in the epidermis of the atopic subgroupEXPERIMENTAL PATHOLOGYDoes the environment influence multiple sclerosis pathogenesis via UVB light and/or induction of vitamin D?Structure and duration of contact between dendritic cells and T cells are controlled by T cell activation stateIL-10 controls ultraviolet-induced carcinogenesis in miceFriend retrovirus infection of myeloid dendritic cells impairs maturation, prolongs contact to naive T cells, and favors expansion of regulatory T cells
P50
Q28118511-ABCD3B2A-E1BA-454A-965A-4DE4D17E83D0Q33529045-B0FD9921-5A32-4869-9F83-E8D57061358FQ34540026-31081C79-5434-4457-B4DE-7E9D4B5C9A2BQ36604434-51576E5A-4596-4133-96D2-BC837952CE19Q37045247-6BA5AD28-F91B-412C-A89D-D351634560FAQ37049512-0E14C958-398B-4EC9-8BE5-AB3172C561B6Q37827460-89BF3E9D-CF2E-46F0-9BDA-552AE0F52376Q38709837-E3A2F63F-620E-4971-A384-CCA2FF2F35C1Q39633865-61D6BCEC-5644-4C08-BDBD-43CCACDF46DFQ40432672-2DFA2549-D5A6-4C52-8D2A-C19504762CDFQ40474467-319F8C63-65B2-492D-956C-85C80B0AC3B1Q41160055-FB34798F-C3CC-40AC-8720-2E33D5291906Q41865300-2A1354CB-826C-4162-AEC7-4828B5D2DF3AQ42129626-CA2D367E-39F3-48A7-80B8-66969DC79D35Q42509581-9392E324-097A-4BC1-B06D-CFE76BE7F646Q42625512-9404826C-8652-479A-AA24-C5173AD5EF93Q44663230-350F1A1C-B016-493D-B6D4-C1192F6BED16Q45166532-F95C6679-5728-40E6-B006-EFDFA838F988Q46763995-3B4EB2B0-A639-4947-A49D-BFE1F071D7F7Q46919125-D8C62B7A-D748-4575-B5C1-CA3EB3CE9369Q46937604-4C3F4CC0-9DF2-435C-89EA-75F13964F464Q47368709-344BB9DA-9939-44C2-A290-24577A1D45C5Q47688274-FEB92FB6-270A-41DD-A5A2-EEB48A0F4177Q50078787-BCC8B737-67A0-4DCB-AC97-BD073D679778Q52767142-C93918B1-69A1-406D-A3B3-107AAD8A4A4BQ53221633-3B567C8C-5A09-4EDF-BF23-B461811461D1Q53659734-ABC3474C-FF40-43D9-A0EE-D2ACE1D07CDCQ57184743-AE5441A7-699F-4560-9AAC-9A9BDE014BE2Q58859816-AD69C7E0-DB6D-4B61-9D0B-35B927EAAFFDQ60175961-30791920-046F-42BD-95D1-79781A8AFBB7Q62898267-856FCE27-AA39-40CE-9273-984180748327Q79366608-4895B7D7-03B8-4F04-94AE-A47EDA2EF77DQ80500065-87246660-4CD8-4DF8-A5F3-22D0EF50B760Q80798015-A3EB5F24-4EA2-43E0-A02B-EB3274C0DB56
P50
description
German biologist and immunologist
@en
deutsche Biologin und Immunologin
@de
name
Karin Loser
@de
Karin Loser
@en
Karin Loser
@nl
Karin Loser
@sl
type
label
Karin Loser
@de
Karin Loser
@en
Karin Loser
@nl
Karin Loser
@sl
prefLabel
Karin Loser
@de
Karin Loser
@en
Karin Loser
@nl
Karin Loser
@sl
P214
P227
P19
P21
P214
P227
P31
P569
1968-12-11T00:00:00Z
P734
P735
P7859
viaf-35300568